InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: jakedogman1 post# 268950

Monday, 07/25/2016 1:37:38 PM

Monday, July 25, 2016 1:37:38 PM

Post# of 345789
Maybe the deal is partially sealed up and close to being finalized? I only want to make sure that another pipeline is not using PS Targeting and Peregrine aware of the full list of PS Targeting uses

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News